Price
CHART BY
Frequently asked questions
What is CareDx's market capitalization?
The market capitalization of CareDx is $1.20B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for CareDx?
CareDx's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.701. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for CareDx's stock?
Currently, 9 analysts cover CareDx's stock, with a consensus target price of $32.38. Analyst ratings provide insights into the stock's expected performance.
What is CareDx's revenue over the trailing twelve months?
Over the trailing twelve months, CareDx reported a revenue of $312.78M.
What is the EBITDA for CareDx?
CareDx's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$39.66M. EBITDA measures the company's overall financial performance.
What is the free cash flow of CareDx?
CareDx has a free cash flow of $1.22M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does CareDx have, and what sector and industry does it belong to?
CareDx employs approximately 643 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of CareDx's shares?
The free float of CareDx is 50.23M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.20B
- EPS (TTM)
- -$2.701
- Free Float
- 50.23M
- Revenue (TTM)
- $312.78M
- EBITDA (TTM)
- -$39.66M
- Free Cashflow (TTM)
- $1.22M
Pricing
- 1D span
- $22.25$23.92
- 52W span
- $7.46$34.83
Analyst Ratings
The price target is $32.38 and the stock is covered by 9 analysts.
Buy
5
Hold
4
Sell
0
Information
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
- Employees
- 643
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US14167L1035
- Primary Ticker
- CDNA
Knockouts
Finance data from FactSet